Lynparza 100 MG tablet UU 120S
Ended Awarded Last action
- Contract number
- SPE2DR26FT6DT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,493
Award facts
- Contract value 100% obligated
- $24,493.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24,493.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 30, 2026, for the supply of Lynparza 100 mg tablets (120-count units). The contract, which is not set-aside, has an ultimate completion date of February 23, 2026, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single task order against AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. The company holds a significant global pharmaceutical supply vehicle that enables it to deliver a comprehensive range of medications, medical supplies, vaccines, and related commodities to support military healthcare programs worldwide. The competitively awarded delivery order for Lynparza, an oncology medication, exemplifies the company's capability to fulfill federal medical supply requirements across multiple therapeutic domains through the DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FT6DT?
SPE2DR26FT6DT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FT6DT worth?
The government has obligated $24,493 on SPE2DR26FT6DT.
Is contract SPE2DR26FT6DT an order under another contract?
Yes. SPE2DR26FT6DT is a delivery order under SPE2DR25D3201, an indefinite delivery contract.
Was contract SPE2DR26FT6DT competed?
The extent of competition for SPE2DR26FT6DT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award